A powerful psychedelic, best known for its intense but brief effects, may offer a new way to treat depression. In a Phase 2 clinical trial at Imperial College London, a single intravenous dose of ...

Add Yahoo as a preferred source to see more of our stories on Google. In an early clinical trial, a single dose of a short-acting psychedelic drug led to rapid improvement in people with major ...

A $1.5 million gift to UC San Diego will help fund a research program into the biological and psychological effect of a powerful psychedelic in humans, it was announced Tuesday. N,N-dimethyltryptamine ...

Add Yahoo as a preferred source to see more of our stories on Google. Interest in psychedelic medicines has accelerated in recent years, and new research focusing on dimethyltryptamine (DMT), the main ...

One person’s recreational drug trip might be another’s mental health boost. Research out today finds that dimethyltryptamine, better known as DMT, could be effective at treating people’s depression.

Algernon Pharmaceuticals’ AGNPF wholly-owned Algernon NeuroScience (AGN Neuro) successfully completed dosing the third and final cohort of its Phase 1 clinical study assessing an intravenous (IV) ...

One of the most powerful psychedelics known, N,N-dimethyltryptamine (DMT) has been described as causing imaginative visuals akin to the dream state. It is typically consumed on its own or in ayahuasca ...

New research suggests that a single dose of the psychedelic compound DMT can reverse symptoms of depression, including loss of pleasure and cognitive decline, in mice subjected to chronic stress. The ...

Entering the field of psychedelic therapy, whether as a therapist or a client, means learning about an ever-growing, sometimes bewildering array of psychedelic substances. My friends in the field have ...

A $1.5 million gift to UC San Diego will help fund a research program into the biological and psychological effect of a powerful psychedelic in humans, it was announced Tuesday. N, ...